Search

Author/Creator Toorawa, Robert

1. Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study. Issue 1 (December 2015)

Authors:
O'Byrne, Paul; D'Urzo, Tony; Beck, Ekkehard; Fležar, Matjaž; Gahlemann, Martina; Hart, Lorna; Blahova, Zuzana; Toorawa, Robert; Beeh, Kai-Michael
Journal:
Respiratory research
Issue:
Volume 16:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Linagliptin and pioglitazone combination therapy versus monotherapy with linagliptin or pioglitazone: A randomised, double-blind, parallel-group, multinational clinical trial. (July 2016)

Authors:
Nauck, Michael Albrecht; di Domenico, Maximiliano; Patel, Sanjay; Kobe, Maureen; Toorawa, Robert; Woerle, Hans-Juergen
Journal:
Diabetes & vascular disease research
Issue:
Volume 13:Number 4(2016:Jul.)
Page Start:
286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma. Issue 1 (December 2015)

Authors:
Beeh, Kai-Michael; LaForce, Craig; Gahlemann, Martina; Wenz, Arne; Toorawa, Robert; Fležar, Matjaž
Journal:
Respiratory research
Issue:
Volume 16:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗